Hyaluronan receptors in the human ocular surface: a descriptive and comparative study of RHAMM and CD44 in tissues, cell lines and freshly collected samples

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Histochemistry and Cell Biology

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00418-011-0878-zPMID 22095138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells

  2011cited by this paper
• Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease

  2010cited by this paper
• RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.

  2009cited by this paper
• Aqueous humor level of sCD44 in patients with degenerative myopia and primary open-angle glaucoma

  2009cited by this paper
• RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53

  2008cited by this paper
• Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?

  2008cited by this paper
• Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation.

  2008cited by this paper
• Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.

  2008cited by this paper
• RHAMM in the complex p53 cell cycle network

  2008cited by this paper
• A Putative Role for RHAMM/HMMR as a Negative Marker of Stem Cell‐Containing Population of Human Limbal Epithelial Cells

  2008influential reference
• Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells

  2008cited by this paper
• The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells*

  2007cited by this paper
• Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.

  2007cited by this paper
• Reduced structural proteins in the conjunctival epithelium in allergic eye disease

  2006cited by this paper
• Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer

  2005cited by this paper
• RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy

  2004cited by this paper
• Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line.

  2004cited by this paper
• The liberation of CD44

  2003cited by this paper
• Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva.

  2003influential reference
• Signaling Properties of Hyaluronan Receptors*

  2002cited by this paper
• The hyaluronan receptor, CD44.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments.

  1999cited by this paper
• The normal structure and function of CD44 and its role in neoplasia.

  1998cited by this paper
• Hyaluronan and CD44 in the human cornea and limbal conjunctiva.

  1998cited by this paper
• Expression and distribution of adhesion molecule CD44 in healing corneal epithelia.

  1998cited by this paper
• CD44: structure, function, and association with the malignant process.

  1997cited by this paper
• Expression of adhesion molecule CD44 on human corneas

  1997cited by this paper
• Flow cytometric analysis of surface antigens on human conjunctival epithelial cells.

  1997cited by this paper
• HA receptors: Regulators of signalling to the cytoskeleton

  1996cited by this paper
• Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.

  1996cited by this paper
• An SV40-immortalized human corneal epithelial cell line and its characterization.

  1995influential reference
• Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression.

  1994cited by this paper
• RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

  1994cited by this paper
• CD44: the hyaluronan receptor.

  1992cited by this paper
• Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility [published erratum appears in J Cell Biol 1992 Aug;118(3):753]

  1992cited by this paper
• Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells

  1991cited by this paper
• CD44 is the principal cell surface receptor for hyaluronate.

  1990cited by this paper
• Purification of a hyaluronate-binding protein fraction that modifies cell social behavior.

  1982cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979influential reference
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Topical Administration of Mucoadhesive Liposomes-Epoetin-β for Targeting the Ocular Posterior Segment.

  2025cites this paper
• A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments.

  2024cites this paper
• Drug Delivery Systems for Infectious Eye Diseases: Advancements and Prospects

  2024cites this paper
• Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents

  2024cites this paper
• The Effect of High Molecular Weight Hyaluronic Acid and Latanoprost Eyedrops on Tear Functions and Ocular Surface Status in C57/BL6 Mice

  2023cites this paper
• Application frequency – key indicator for the efficiency of severe dry eye disease treatment – evidence for the importance of molecular weight of hyaluronan in lubricating agents

  2023cites this paper
• Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review.

  2023cites this paper
• Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye

  2023cites this paper
• Reflections on the Ocular Surface: Summary of the Presentations at the 4th Coronis Foundation Ophthalmic Symposium Debate: "A Multifactorial Approach to Ocular Surface Disorders" (August 31 2021).

  2022cites this paper
• Insight on updates in polysaccharides for ocular drug delivery.

  2022cites this paper
• Hyaluronic Acid: Its Versatile Use in Ocular Drug Delivery with a Specific Focus on Hyaluronic Acid-Based Polyelectrolyte Complexes

  2022cites this paper
• Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease

  2022cites this paper
• Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives.

  2021cites this paper
• Preparation of Liposomal Formulations for Ocular Delivery of Thymoquinone: In Vitro Evaluation in HCEC-2 e HConEC Cells

  2021cites this paper
• Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues

  2021cites this paper
• The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review.

  2020cites this paper
• Tear 1H Nuclear Magnetic Resonance-Based Metabolomics Application to the Molecular Diagnosis of Aqueous Tear Deficiency and Meibomian Gland Dysfunction

  2020cites this paper
• Detection of TSG-6-like protein in human corneal epithelium. Simultaneous presence with CD44 and hyaluronic acid.

  2020cites this paper
• Layer-by-layer nanoparticles for glaucoma therapy

  2020cites this paper
• Selecting Appropriate Reference Genes for Quantitative Real-Time Polymerase Chain Reaction Studies in Isolated and Cultured Ocular Surface Epithelia

  2019cites this paper
• In vivo and ex vivo evaluation of cell–cell interactions, adhesion and migration in ocular surface of patients undergone excimer laser refractive surgery after topical therapy with different lubricant eyedrops

  2018cites this paper
• Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye

  2018influential citation
• Visualization of Ovarian Cancer Cells with Peptide VEGEGEEGEEY

  2018cites this paper
• Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride.

  2018cites this paper
• Hyaluronan as a promising excipient for ocular drug delivery

  2017cites this paper
• Verträglichkeit von Hyaluronsäure zur Oberflächenpflege nach perforierender Keratoplastik

  2016cites this paper
• Hyaluronate Acid-Dependent Protection and Enhanced Corneal Wound Healing against Oxidative Damage in Corneal Epithelial Cells

  2016cites this paper
• Thrombospondin-1 induces differential response in human corneal and conjunctival epithelial cells lines under in vitro inflammatory and apoptotic conditions.

  2015cites this paper
• Estudio de los mediadores inflamatorios en la fotofobia durante la cicatrización corneal post cirugía refractiva

  2013cites this paper
• The Histochemistry and Cell Biology compendium: a review of 2012

  2013influential citation
• Transporters and receptors in the posterior segment of the eye

  2013cites this paper
• Modelo in vitro de inflamación corneal causada por lentes de contacto

  2012cites this paper
• CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation

  2012cites this paper